Skip to content
10-Q

Quarterly Report

RayzeBio, Inc.

0001628280-23-038595

← back to feed
Filed
Nov 13, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 7, 2023 59.92M sh
Shares Diluted Q3 2023 · Sep 30, 2023 15.4M sh
Shares Diluted Q3 2023 · Sep 30, 2023 8.35M sh
Shares Diluted Q3 2023 · Sep 30, 2022 3.82M sh
Shares Diluted Q3 2023 · Sep 30, 2022 3.41M sh
Stock Repurchased Q3 2023 · Sep 30, 2023 $0
Stock Repurchased Q3 2023 · Sep 30, 2022 $1.88M
Capex Q3 2023 · Sep 30, 2023 $31.81M
Capex Q3 2023 · Sep 30, 2022 $6.3M
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$45.26M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$40.89M
Short Term Investments Q3 2023 · Sep 30, 2023 $288.21M
Short Term Investments Q3 2023 · Dec 31, 2022 $167.09M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $251.96M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $129.16M
Cash And Equivalents Q3 2023 · Sep 30, 2022 $215.59M
Stockholders Equity Q3 2023 · Sep 30, 2023 $575.32M
Stockholders Equity Q3 2023 · Jun 30, 2023 −$135.49M
Stockholders Equity Q3 2023 · Dec 31, 2022 −$111.29M
Stockholders Equity Q3 2023 · Sep 30, 2022 −$99.29M
Stockholders Equity Q3 2023 · Jun 30, 2022 −$87.15M
Stockholders Equity Q3 2023 · Dec 31, 2021 −$54.57M
Current Liabilities Q3 2023 · Sep 30, 2023 $17.11M
Current Liabilities Q3 2023 · Dec 31, 2022 $10.46M
Current Assets Q3 2023 · Sep 30, 2023 $544.99M
Current Assets Q3 2023 · Dec 31, 2022 $300.04M
Total Assets Q3 2023 · Sep 30, 2023 $603.51M
Total Assets Q3 2023 · Dec 31, 2022 $324.78M
Eps Diluted Q3 2023 · Sep 30, 2023 −$1.26
Eps Diluted Q3 2023 · Sep 30, 2023 −$5.99
Eps Diluted Q3 2023 · Sep 30, 2022 −$6.55
Eps Diluted Q3 2023 · Sep 30, 2022 −$17.14
Eps Basic Q3 2023 · Sep 30, 2023 −$1.26
Eps Basic Q3 2023 · Sep 30, 2023 −$5.99
Eps Basic Q3 2023 · Sep 30, 2022 −$6.55
Eps Basic Q3 2023 · Sep 30, 2022 −$17.14
Sga Expense Q3 2023 · Sep 30, 2023 $3.48M
Sga Expense Q3 2023 · Sep 30, 2023 $9.48M
Sga Expense Q3 2023 · Sep 30, 2022 $2.12M
Sga Expense Q3 2023 · Sep 30, 2022 $8.24M
Rd Expense Q3 2023 · Sep 30, 2023 $18.17M
Rd Expense Q3 2023 · Sep 30, 2023 $48.76M
Rd Expense Q3 2023 · Sep 30, 2022 $18.83M
Rd Expense Q3 2023 · Sep 30, 2022 $46.42M
Net Income Q3 2023 · Sep 30, 2023 −$18.19M
Net Income Q3 2023 · Sep 30, 2023 −$48.8M
Net Income Q3 2023 · Sep 30, 2022 −$20.45M
Net Income Q3 2023 · Sep 30, 2022 −$53.9M
Operating Income Q3 2023 · Sep 30, 2023 −$21.65M
Operating Income Q3 2023 · Sep 30, 2023 −$58.24M
Operating Income Q3 2023 · Sep 30, 2022 −$20.95M
Operating Income Q3 2023 · Sep 30, 2022 −$54.66M